Revelation Biosciences Warrant
REVBW
11 hedge funds and large institutions have $10.2K invested in Revelation Biosciences Warrant in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
21% less capital invested
Capital invested by funds: $13K → $10.2K (-$2.76K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$12 |
| 2 |
CS
Clear Street
New York
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $2.41K | – | – | – |
|
|
CS
2
Clear Street
New York
| $1.98K | -$1 | -100 | -0% |
|
|
PVI
3
Pine Valley Investments
Marlton,
New Jersey
| $1.96K | – | – | – |
|
|
TC
4
T3 Companies
New York
| $1.58K | +$2.14K | +198,090 | New |
|
5
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $796 | – | – | – |
|
|
WAM
6
Wolverine Asset Management
Chicago,
Illinois
| $438 | – | – | – |
|
7
Jane Street
New York
| $400 | – | – | – |
|
|
SIA
8
Soltis Investment Advisors
St. George,
Utah
| $380 | – | – | – |
|
|
9
Citadel Advisors
Miami,
Florida
| $257 | +$3 | +300 | +0.9% |
|
|
PIS
10
POM Investment Strategies
Raleigh,
North Carolina
| $8 | – | – | – |
|
|
QWM
11
Quaker Wealth Management
Moorestown,
New Jersey
| $4 | – | – | – |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$12 | -1,133 | Closed |
|
REVBW Hedge Fund Activity: Q4 2025 in Review
11 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q4 2025, worth a combined $10.2K — down 21% from $13K a quarter earlier.
Fund positioning in REVBW was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $3. The largest seller was UBS Group, exiting entirely with an estimated $12 sold.
- 11 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $10.2K of Revelation Biosciences Warrant stock for Q4 2025, down 21% quarter-over-quarter.
- 1 fund opened new Revelation Biosciences Warrant positions in Q4 2025 and 1 closed out, a net change of 0 holders.
- The largest Revelation Biosciences Warrant buyer in Q4 2025 was Citadel Advisors, an estimated $3 added.
- The largest Revelation Biosciences Warrant seller in Q4 2025 was UBS Group, an estimated $12 sold.
Based on aggregated 13F filings for Q4 2025.